<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04682626</url>
  </required_header>
  <id_info>
    <org_study_id>2020-PHA-23</org_study_id>
    <nct_id>NCT04682626</nct_id>
  </id_info>
  <brief_title>Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels in People With Vitamin D Deficiency: A Randomized Controlled 10-weeks Follow-up Trial.</brief_title>
  <official_title>Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels in People With Vitamin D Deficiency: A Randomized Controlled 10-weeks Follow-up Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applied Science Private University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applied Science Private University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among Jordanians, there is a high prevalence of T2DM. VDD has also spread rapidly in the past&#xD;
      decade. Preliminary results of recent studies have shown that VD3 has a potential role in&#xD;
      reducing FBG. Notably, the impact of VD3 supplementation on glycemic control in diabetics, as&#xD;
      well as pre-diabetics, remains highly controversial. Some studies have shown that osteocalcin&#xD;
      (OSC) is correlated with fat mass, sensitivity to and secretion of insulin, glucose&#xD;
      metabolism, and glycemic variability. In mice, OSC injections improved insulin sensitivity&#xD;
      and prevent obesity. A more recent study has found that T2DM was inversely correlated with&#xD;
      osteocalcin levels . There is a strong correlation between OSC and fibroblastic factor -23&#xD;
      (FBF-23). Many recent studies have correlated FBF-23 as well as vitamin D levels with some of&#xD;
      the pathological conditions such as chronic kidney failure, atherosclerosis, and diabetes.&#xD;
      They stated possible interrelationships between insulin resistance, Hyperinsulinemia, and/or&#xD;
      lower VD3 levels may lead to decreased serum FGF-23 concentrations in obese children and&#xD;
      adolescents. Therefore, serum FGF-23 has been suggested to be a potential indicator of&#xD;
      subclinical atherosclerosis in patients with gestational diabetes mellitus. Based on these&#xD;
      data, we expect that a high dose of vitamin D will significantly influence the association&#xD;
      between A1c with FGF-23 levels in people with vitamin D deficiency.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 25, 2020</start_date>
  <completion_date type="Anticipated">March 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single (Participant)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>FGF-23</measure>
    <time_frame>10 weeks</time_frame>
    <description>plasma levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A1c</measure>
    <time_frame>10 weeks</time_frame>
    <description>plasma percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osteocalcin</measure>
    <time_frame>10 weeks</time_frame>
    <description>plasma levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>25OHD</measure>
    <time_frame>10 weeks</time_frame>
    <description>serum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>VD3 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary Supplement: Soft gelatin capsules each contain 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg once weekly for 8 weeks.&#xD;
.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.</intervention_name>
    <description>Soft gelatin capsules each contain 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.</description>
    <arm_group_label>VD3 group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria included males and females in the age range of 22-55 years with a&#xD;
             medical diagnosis of vitamin D deficiency.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects with any chronic disease such as kidney failure, CVD, diabetes, blood&#xD;
             disorders, or immune problems, including autoimmune diseases, chronic or severe&#xD;
             infections will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud S Abu-Samak, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sara Al-imam, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud S Abu-Samak, PhD</last_name>
    <phone>009627998920</phone>
    <phone_ext>1104</phone_ext>
    <email>m_abusamak@asu.edu.jo</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luai z Hasoun, PhD</last_name>
    <phone>00962785266441</phone>
    <phone_ext>1104</phone_ext>
    <email>l_hasoun@asu.edu.jo</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mahmoud S Abu-Samak</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud S Abu-Samak, PhD</last_name>
      <phone>009627998920</phone>
      <email>m_abusamak@asu.edu.jo</email>
    </contact>
    <contact_backup>
      <last_name>luai z Hasoun, PhD</last_name>
      <phone>00962785266441</phone>
      <email>l_hasoun@asu.edu.jo</email>
    </contact_backup>
    <investigator>
      <last_name>Sara M Al-Imam, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <results_reference>
    <citation>Abu-Samak MS, AbuRuz ME, Masa'Deh R, Khuzai R, Jarrah S. Correlation of selected stress associated factors with vitamin D deficiency in Jordanian men and women. Int J Gen Med. 2019 Jun 28;12:225-233. doi: 10.2147/IJGM.S198175. eCollection 2019.</citation>
    <PMID>31303782</PMID>
  </results_reference>
  <results_reference>
    <citation>Al-Shaer AH, Abu-Samak MS, Hasoun LZ, Mohammad BA, Basheti IA. Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiency. Clin Pharmacol. 2019 Feb 4;11:25-37. doi: 10.2147/CPAA.S182927. eCollection 2019.</citation>
    <PMID>30787641</PMID>
  </results_reference>
  <results_reference>
    <citation>Abu-Hasheesh MO, Abu-Samak MS, Al-Matubsi HY, Jaradeh MS, Jarrah SS, Khuzaie RF. Association of parental history of type 2 diabetes mellitus with leptin levels in Jordanian male youths. Saudi Med J. 2010 Aug;31(8):882-6.</citation>
    <PMID>20714685</PMID>
  </results_reference>
  <results_reference>
    <citation>Abu-Taha M, Dagash R, Mohammad BA, Basheiti I, Abu-Samak MS. Combined Effect Of Coffee Consumption And Cigarette Smoking On Serum Levels Of Vitamin B12, Folic Acid, And Lipid Profile In Young Male: A Cross-Sectional Study. Int J Gen Med. 2019 Nov 22;12:421-432. doi: 10.2147/IJGM.S213737. eCollection 2019. Erratum in: Int J Gen Med. 2020 Feb 04;13:27.</citation>
    <PMID>31819593</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 19, 2020</study_first_submitted>
  <study_first_submitted_qc>December 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>December 19, 2020</last_update_submitted>
  <last_update_submitted_qc>December 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Applied Science Private University</investigator_affiliation>
    <investigator_full_name>Mahmoud Suleiman Abu-Samak</investigator_full_name>
    <investigator_title>Mahmoud S Abu-Samak, PhD Study Principal Investigator Department of Clinical Pharmacy and Therapeutics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

